<DOC>
	<DOCNO>NCT01320878</DOCNO>
	<brief_summary>The objective study assess efficacy appropriate dose iloprost inhalation treatment postoperative pulmonary hypertension child congenital heart defect .</brief_summary>
	<brief_title>Study Inhaled Iloprost Treatment Pulmonary Hypertension After Repair Congenital Heart Disease</brief_title>
	<detailed_description>Pulmonary hypertension serious postoperative complication child congenital heart defect , high incidence mortality . Iloprost prostacyclin analogue . When applied inhalation , selectively dilate pulmonary vessel , without side affect systemic circulation . No randomized control trial ( RCT ) iloprost previously perform indication . The investigator study first RCT iloprost inhalation surgery child 's congenital heart diseases performed field .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Before corrective procedure CHD , two bellow ten criteria meet : Decreased respiratory infection &amp; decreased exercise tolerance Pulse SaO2 &lt; 93 % leftright shunt CHD case ( room air ) EKG : right ventricular hypertrophy , right atrial dilatation Chest Xray : enhanced vascular sign transhilar , loss blood vessel bilateral lung field , pulmonary arterial trunk dilatation , right ventricular enlargement Cardiac echocardiography : fast tricuspid pulmonary valve regurgitant velocity , ventricular aortic level bidirectional shunt , even righttoleft shunt Underfilling pulmonary capillary , 'pruning ' peripheral blood vessel Pp/Ps &gt; 0.75 Qp/Qs &lt; 1.5 PVR &gt; 9WU/m2 Rp/Rs &gt; 0.5 body weight &lt; 2 kg , prematurity ( birth 36 week postconceptual age ) renal dysfunction ( creatinine &gt; = 1.5 mg/dL 48 hour surgery ) PLT &lt; 50,000*109/L obvious bleed LCOS hypotension arrival intensive care unit After corrective procedure CHD : deficient anatomy associate remain intracardiac shunt severe artrioventricular regurgitation severe arrhythmia lead low cardiac output</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>pulmonary hypertension</keyword>
</DOC>